Q87UG3 AF NFT

1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeiemoftk3ojunfjuz7gnfjxbhptvsily5jftizsfmwwr4ha6cq3wbe/metadata.json

IPFS of structure file:

bafybeigxar7t7szgqr2nc472ur5x2e6xq2qudkcu2h3ka52en2obijms2a/AF-Q87UG3-F1-model_v2.pdb

First NFT owner address (eip-55):

0x2d54E4F6297333Fee90b3BDa235404b5BeAc5B51

First NFT owner address (bech32):

genesis1942wfa3fwvela6gt80dzx4qykkl2ck636fpkfp

Current NFT ID #171370 owner (web3):

0x8F9c7747101075C570E34CAd4Ed2A4C01e9b2C28

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
171370
Accession (UniProt):
Q87UG3
Name::
1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
Experimental Method:
Predicted structure
Sequence source:
PSEUDOMONAS SYRINGAE PV. TOMATO (STRAIN ATCC BAA-871 / DC3000)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q87UG3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q87UG3|HIS4_PSESM 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase OS=Pseudomonas syringae pv. tomato (strain ATCC BAA-871 / DC3000) OX=223283 GN=hisA PE=3 SV=1 MLIIPAIDLKDGACVRLRQGRMEDSTVFSDDPVAMAAKWVDGGCRRLHLVDLNGAFEGQPVNGDVVTAIAKRYPNLPIQIGGGIRSLETIEHYIKAGVSYVIIGTKAVKDPEFVAQACRAFPGKVIVGLDAKDGFVATDGWAEVSTVQVIDLAKRFEADGVSAIVYTDIAKDGMMQGCNIPFTAALAAATRIPVIASGGIHNLGDIQALLNAKAPGIIGAITGRAIYEGTLDVAEAQALCDREQR

MOLNFT AF v1_w

NFT data

MOLNFT Q87UG3 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience